# Tribute Pharmaceuticals Canada Inc.

Tribute Pharmaceuticals Canada Inc. is a company headquartered in London, Canada.

## Company overview

- **Legal name:** Tribute Pharmaceuticals Canada Inc.
- **Former names in filing history:** STELLAR PHARMACEUTICALS INC (2005-11-23 to 2012-11-21); STELLAR INTERNATIONAL INC (2002-02-06 to 2006-04-12)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** London, Canada
- **Incorporated in:** Ontario, Canada
- **Fiscal year end:** December 31
- **SEC CIK:** 0001159019

## About

Tribute Pharmaceuticals Canada Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001159019, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2015-03-03, it reported annual revenue of CAD 16,871,792; net income of CAD -5,606,942; total assets of CAD 53,079,740 for the fiscal period ended 2014-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2014 (period ended 2014-12-31)

- **Revenue:** CAD 16.9M (CAD 16,871,792)
- **Net income:** -CAD 5.6M (CAD -5,606,942)
- **Total assets:** CAD 53.1M (CAD 53,079,740)
- **Cash and equivalents:** CAD 3.5M (CAD 3,505,791)
- **Operating cash flow:** -CAD 1.9M (CAD -1,888,085)

### FY2013 (period ended 2013-12-31)

- **Revenue:** CAD 13.4M (CAD 13,440,361)
- **Net income:** -CAD 6.6M (CAD -6,572,355)
- **Total assets:** CAD 20.0M (CAD 20,034,541)
- **Cash and equivalents:** CAD 2.8M (CAD 2,813,472)
- **Operating cash flow:** -CAD 5.5M (CAD -5,537,596)
- **Later filings:** Operating cash flow: shown as originally filed; later filings report different values for the same periods.

### FY2012 (period ended 2012-12-31)

- **Revenue:** CAD 12.3M (CAD 12,342,783)
- **Net income:** -CAD 3.3M (CAD -3,348,966)
- **Total assets:** CAD 20.8M (CAD 20,828,532)
- **Cash and equivalents:** CAD 2.3M (CAD 2,283,868)
- **Operating cash flow:** -CAD 1.6M (CAD -1,557,727)

## Recent SEC filings

- Form SC 13G — filed 2016-02-16
- Form 8-K — filed 2016-02-11 — period 2016-02-05 — CURRENT REPORT
- Form 8-K — filed 2016-02-05 — period 2016-02-05 — CURRENT REPORT
- Form 8-K — filed 2016-02-01 — period 2016-02-01 — CURRENT REPORT
- Form 8-K — filed 2016-01-21 — period 2016-01-21 — CURRENT REPORT
- Form 8-K — filed 2016-01-11 — period 2016-01-11 — CURRENT REPORT
- Form 8-K — filed 2016-01-04 — period 2016-01-04 — CURRENT REPORT
- Form 8-K — filed 2015-12-28 — period 2015-12-28 — CURRENT REPORT
- Form 8-K — filed 2015-12-08 — period 2015-12-07 — CURRENT REPORT
- Form 8-K — filed 2015-11-23 — period 2015-11-23 — CURRENT REPORT
- Form 8-K — filed 2015-11-09 — period 2015-11-06 — CURRENT REPORT
- Form 8-K — filed 2015-11-09 — period 2015-11-09 — CURRENT REPORT

---

Updated: 2026-10-23T20:06:36Z

Canonical page: https://altss.com/profile/tribute-pharmaceuticals-canada-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology